Levalbuterol is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Ritedose Pharmaceuticals,. The primary component is Levalbuterol Hy.
| Product ID | 76204-800_7d4dd0e8-6b46-38a3-e053-2991aa0a7fee |
| NDC | 76204-800 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levalbuterol |
| Generic Name | Levalbuterol Hydrochloride |
| Dosage Form | Solution |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2016-03-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203653 |
| Labeler Name | Ritedose Pharmaceuticals, |
| Substance Name | LEVALBUTEROL HY |
| Active Ingredient Strength | 1 mg/3mL |
| Pharm Classes | Adrenergic beta |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-02-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-02-17 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-03 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-03 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-03-03 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-03-22 |
| Marketing End Date | 2019-04-09 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-02-17 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-17 |
| Marketing Category | ANDA |
| Application Number | ANDA203653 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-02-17 |
| Marketing End Date | 2019-04-09 |
| Ingredient | Strength |
|---|---|
| LEVALBUTEROL HYDROCHLORIDE | .63 mg/3mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-4145 | Levalbuterol | Levalbuterol |
| 0093-4146 | Levalbuterol | Levalbuterol |
| 0093-4147 | Levalbuterol | Levalbuterol |
| 0093-4148 | Levalbuterol | Levalbuterol |
| 0115-9930 | Levalbuterol | Levalbuterol Hydrochloride |
| 0115-9931 | Levalbuterol | Levalbuterol Hydrochloride |
| 0115-9932 | Levalbuterol | Levalbuterol Hydrochloride |
| 0378-6993 | Levalbuterol | levalbuterol |
| 0378-9680 | Levalbuterol | levalbuterol |
| 0378-9681 | Levalbuterol | levalbuterol |
| 0378-9682 | Levalbuterol | levalbuterol |
| 0378-9690 | Levalbuterol | Levalbuterol |
| 0378-9691 | Levalbuterol | Levalbuterol |
| 0378-9692 | Levalbuterol | Levalbuterol |
| 68788-6777 | Levalbuterol | Levalbuterol |
| 76204-900 | Levalbuterol | Levalbuterol |
| 76204-800 | Levalbuterol | Levalbuterol |
| 76204-700 | Levalbuterol | Levalbuterol |
| 63187-953 | Levalbuterol | Levalbuterol |
| 65862-944 | Levalbuterol | Levalbuterol |
| 65862-942 | LEVALBUTEROL | LEVALBUTEROL |
| 65862-945 | Levalbuterol | Levalbuterol |
| 65862-943 | Levalbuterol | Levalbuterol |
| 68071-5027 | Levalbuterol | Levalbuterol |
| 68071-2340 | Levalbuterol | Levalbuterol |
| 17478-171 | Xopenex | Levalbuterol Hydrochloride |
| 17478-172 | Xopenex | Levalbuterol Hydrochloride |
| 17478-173 | Xopenex | Levalbuterol Hydrochloride |
| 17478-174 | Xopenex | Levalbuterol Hydrochloride |
| 21695-153 | Xopenex | levalbuterol hydrochloride |